Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Whittaker

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|May 29, 2009
Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ringDelphine Ménard, Ion Niculescu-Duvaz, Harmen P Dijkstra, et al.
Journal of Hepatology|January 16, 2013
Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy studyPablo Bellot, Martin-Walter Welker, German Soriano, et al.
Bioorganic & Medicinal Chemistry|July 30, 2010
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffoldsDan Niculescu-Duvaz, Ion Niculescu-Duvaz, Bart M J M Suijkerbuijk, et al.
Journal of Medicinal Chemistry|March 28, 2009
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF)Dan Niculescu-Duvaz, Catherine Gaulon, Harmen P Dijkstra, et al.
Journal of Medicinal Chemistry|March 5, 2010
Development of novel, highly potent inhibitors of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF): increasing cellular potency through optimization of a distal heteroaromatic groupBart M J M Suijkerbuijk, Ion Niculescu-Duvaz, Catherine Gaulon, et al.
Cancer Cell|December 16, 2014
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanomaMaria Romina Girotti, Filipa Lopes, Natasha Preece, et al.
Cancer Discovery|November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanomaEliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.
Scientific Reports|November 4, 2022
Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assaysOlivier A Pierrat, Manjuan Liu, Gavin W Collie, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Medicinal Chemistry|May 29, 2009
Novel potent BRAF inhibitors: toward 1 nM compounds through optimization of the central phenyl ringDelphine Ménard, Ion Niculescu-Duvaz, Harmen P Dijkstra, et al.
Journal of Hepatology|January 16, 2013
Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy studyPablo Bellot, Martin-Walter Welker, German Soriano, et al.
Bioorganic & Medicinal Chemistry|July 30, 2010
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffoldsDan Niculescu-Duvaz, Ion Niculescu-Duvaz, Bart M J M Suijkerbuijk, et al.
Journal of Medicinal Chemistry|March 28, 2009
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF)Dan Niculescu-Duvaz, Catherine Gaulon, Harmen P Dijkstra, et al.
Journal of Medicinal Chemistry|March 5, 2010
Development of novel, highly potent inhibitors of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF): increasing cellular potency through optimization of a distal heteroaromatic groupBart M J M Suijkerbuijk, Ion Niculescu-Duvaz, Catherine Gaulon, et al.
Cancer Cell|December 16, 2014
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanomaMaria Romina Girotti, Filipa Lopes, Natasha Preece, et al.
Cancer Discovery|November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanomaEliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.
Scientific Reports|November 4, 2022
Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assaysOlivier A Pierrat, Manjuan Liu, Gavin W Collie, et al.
Pageof 2